Induced pluripotent stem cell-derived platelets kill multidrug-resistant Staphylococcus aureus via Toll-like receptor 2-MyD88 signaling and immunoglobulin G/FcγRIIA engagement
Collectively, our findings highlight the direct antimicrobial potential of iPSC-PLTs and provide mechanistic insights, particularly into the contribution of the Toll-like receptor-MyD88 axis. This study provided a basis for applying iPSC-PLTs as a novel therapeutic modality for combating MRSA infections and a genetically modifiable platform for investigating unknown platelet function within the context of antimicrobial immunity.
Authors
- Sou Nakamura (ORCID: https://orcid.org/0000-0002-5601-9777)
- Shigetada Kawabata (ORCID: https://orcid.org/0009-0005-1660-9544)
- Ieva Stirblytė
- Masao Yamaguchi (ORCID: https://orcid.org/0000-0003-0728-1362)
- Naoshi Sugimoto (ORCID: https://orcid.org/0000-0002-7271-9175)
- Koji Eto
- Victor Nizet
- Kimiko Nonomura
- Qirui Lin
- Satoshi Uchiyama
- Katsue Suzuki-Inoue
- Miki Nagao
Institutions
- Osaka University of Economics (JP)
- Chiba University (JP)
- Kyoto University (JP)
- University of California San Diego (US)
- National Institute of Biomedical Innovation, Health and Nutrition (JP)
- University of Yamanashi (JP)
- University of Montana (US)
- The University of Osaka (JP)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.rpth.2026.103374
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00